No Signboard Holdings Ltd - Balloting Results

Posted by Mr. IPO February 13, 2024

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist. The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am. Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases. SAM has strategic collaborations with public and private institutions for research and clinical work. SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

No Signboard Holdings Ltd ("No Signboard" or the "Company") announced that its IPO of 65,734,500 shares received overwhelming response from investors.

At the close of IPO, the public tranche of 2.5m shares was 268.6x subscribed.

Commenting on the strong support for the IPO, Mr Sam Lim (林荣森), Executive Chairman and Chief Executive Officer of No Signboard said, "We are very encouraged by the overwhelming response to our IPO from cornerstone investors, institutional investors and the public, as they clearly recognise our growth potential. We have had over 30 successful years in the F&B business and to bring the Group to the next level, with the aim of delivering significant growth in shareholders' value, we will focus on our expansion roadmap that includes launching a new casual dining concept, expanding our premium beer operations and venturing into the ready meal business."